Literature DB >> 17983873

Computed tomographic scan-diagnosed chronic obstructive pulmonary disease-emphysema: eotaxin-1 is associated with bronchodilator response and extent of emphysema.

Marina Miller1, Joe Ramsdell, Paul J Friedman, Jae Youn Cho, Marian Renvall, David H Broide.   

Abstract

BACKGROUND: Bronchodilator responses are a hallmark of asthma and a subset of chronic obstructive pulmonary disease (COPD). We evaluated subjects with COPD and computed tomographic (CT) scan evidence of emphysema to determine the biomarker profile associated with a bronchodilator response.
OBJECTIVE: We investigated whether subjects with COPD and a bronchodilator response had increased levels of bronchoalveolar lavage (BAL) fluid eosinophil biomarkers, T(H)2 cytokines, CC chemokines, and serum allergen-specific IgE.
METHODS: All patients with COPD and control subjects (n = 31) had chest CT scans to detect emphysema and subsequent pulmonary function studies, BAL for biomarkers, and serum IgE measurements.
RESULTS: CT scan score, FEV(1), carbon monoxide single-breath diffusion capacity, and BAL fluid neutrophil biomarker levels were similar in subjects with COPD who had or did not have a bronchodilator response of greater than 12%. In contrast, levels of BAL fluid eosinophil biomarkers (eosinophil cationic protein [ECP] and eotaxin-1) were greater in patients with COPD with a bronchodilator response, whereas T(H)2 cytokines were not detectable in any patients with COPD. BAL fluid ECP and eotaxin-1 levels correlated with CT scan extent of emphysema. Immunostaining of COPD lung sections from a separate cohort of subjects with COPD and healthy subjects demonstrated epithelial expression of eotaxin-1 but no lung expression of IL-4 or IL-5.
CONCLUSION: Subjects with COPD diagnosed on the basis of the presence of emphysema on CT scan who have a bronchodilator response have increased levels of BAL ECP and eotaxin-1 but not T(H)2 cytokines. CLINICAL IMPLICATIONS: Eosinophil biomarkers (ECP-1 and eotaxin-1) might identify a subset of subjects with COPD with emphysema on CT scans who have a bronchodilator response and an increased extent of emphysema on CT scanning.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17983873     DOI: 10.1016/j.jaci.2007.08.045

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  11 in total

1.  Persistent airway inflammation and emphysema progression on CT scan in ex-smokers observed for 4 years.

Authors:  Marina Miller; Jae Youn Cho; Alexa Pham; Paul J Friedman; Joe Ramsdell; David H Broide
Journal:  Chest       Date:  2010-10-21       Impact factor: 9.410

2.  Genetic association analysis of COPD candidate genes with bronchodilator responsiveness.

Authors:  Woo Jin Kim; Craig P Hersh; Dawn L DeMeo; John J Reilly; Edwin K Silverman
Journal:  Respir Med       Date:  2008-12-25       Impact factor: 3.415

3.  CD8 chemokine receptors in chronic obstructive pulmonary disease.

Authors:  L J C Smyth; C Starkey; F S Gordon; J Vestbo; D Singh
Journal:  Clin Exp Immunol       Date:  2008-08-22       Impact factor: 4.330

4.  Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease.

Authors:  M Bafadhel; M McCormick; S Saha; S McKenna; M Shelley; B Hargadon; V Mistry; C Reid; D Parker; P Dodson; M Jenkins; A Lloyd; P Rugman; Paul Newbold; C E Brightling
Journal:  Respiration       Date:  2011-09-07       Impact factor: 3.580

5.  The role of CT scanning in multidimensional phenotyping of COPD.

Authors:  Mona Bafadhel; Imran Umar; Sumit Gupta; J Vimal Raj; Dhiraj D Vara; James J Entwisle; Ian D Pavord; Christopher E Brightling; Salman Siddiqui
Journal:  Chest       Date:  2011-03-31       Impact factor: 9.410

6.  Distal airway dysfunction identifies pulmonary inflammation in asymptomatic smokers.

Authors:  Kenneth I Berger; Deepak R Pradhan; Roberta M Goldring; Beno W Oppenheimer; William N Rom; Leopoldo N Segal
Journal:  ERJ Open Res       Date:  2016-11-29

Review 7.  Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease.

Authors:  Donald P Tashkin; Michael E Wechsler
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-01-17

8.  Eosinophil and T cell markers predict functional decline in COPD patients.

Authors:  Jeanine M D'Armiento; Steven M Scharf; Michael D Roth; John E Connett; Andrew Ghio; David Sternberg; Jonathan G Goldin; Thomas A Louis; Jenny T Mao; George T O'Connor; Joe W Ramsdell; Andrew L Ries; Neil W Schluger; Frank C Sciurba; Melissa A Skeans; Helen Voelker; Robert E Walter; Christine H Wendt; Gail G Weinmann; Robert A Wise; Robert F Foronjy
Journal:  Respir Res       Date:  2009-11-19

Review 9.  Cytokine inhibition in the treatment of COPD.

Authors:  Gaetano Caramori; Ian M Adcock; Antonino Di Stefano; Kian Fan Chung
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-04-28

10.  The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes.

Authors:  Brendan J Carolan; Grant Hughes; Jarrett Morrow; Craig P Hersh; Wanda K O'Neal; Stephen Rennard; Sreekumar G Pillai; Paula Belloni; Debra A Cockayne; Alejandro P Comellas; Meilan Han; Rachel L Zemans; Katerina Kechris; Russell P Bowler
Journal:  Respir Res       Date:  2014-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.